A transforming growth factor-β1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura

Annals of Hematology

Volumn 79, Issue 9, 2000, Pages 507-513

  Andersson, P O ^a   Stockelberg, D ^a   Jacobsson, S ^a   Wadenvik, H ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bystander immune suppression; ITP; T cell activation; TGF 1

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MALE; PRIORITY JOURNAL; REMISSION; SPLENECTOMY; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; THROMBOCYTOPENIC PURPURA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; CYTOKINES; FEMALE; HUMAN; IMMUNE TOLERANCE; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; REMISSION INDUCTION; SUPPORT, NON-U.S. GOV'T; TH1 CELLS; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033797107     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770000177     Document Type: Article

References (51)

1. A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis
2. Platelet kinetics in idiopathic thrombocytopenic purpura (ITP) before and at different times after splenectomy
3. Transforming growth factor β (TGF-β)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4+ T cell lines
4. Protein A immunoadsorption in chronic refractory ITP reverses increased platelet activation but fails to achieve sustained clinical benefit
5. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
6. Plasma p-selectin is increased in thrombotic consumptive platelet disorders
7. Transforming growth factor β1 has differential effects on B cell proliferation and activation antigen expression
8. Effects of interferon-α therapy on immune parameters in immune thrombocytopenic purpura
9. Plasma soluble interleukin-2 receptor levels in patients with idiopathic thrombocytopenic purpura
10. Synthesis of transforming growth factor-β1 by megakaryocytes and its localization to megakaryocyte and platelet α-granules
11. Directions for research in autoimmune thrombocytopenic purpura (ITP)
12. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis
13. The clinical outcome of autoimmune thrombocytopenic purpura is related to their T-cell immunodeficiency
14. Severe chronic thrombocytopenic purpura is associated with an expansion of CD56+CD3- natural killer cells subset
15. Persistent lymphocytosis of natural killer cells in autoimmune thrombocytopenic purpura (ATP) patients after splenectomy
16. The role of transforming growth factor beta in the generation of suppression: An interaction between CD8+ T cells and NK cells
17. Generation of an inhibitory circuit involving CD8+ T cells, IL-2 and NK cell-derived TGF-β: Contrasting effects anti-CD2 and anti-CD3
18. Megakaryocytopoeitic cytokines in autoimmune thrombocytopenic purpura
19. Thrombopoietin, interleukin-6, and P-selectin at diagnosis and during post-steroid recovery period of patients with autoimmune thrombocytopenic purpura
20. Transforming growth factor-β inhibits IL-4 and IFN-γ production by stimulated human T cells
21. The immunoregulatory effects of NK cells: The role of TGF-β and implications for autoimmunity
22. Do natural killer ceils regulate B cell activity?
23. Transforming growth factor β1 is an important immunomodulatory protein for human B lymphocytes
24. Tγ cell deficiency in idiopathic thrombocytopenic purpura (ITP)
25. Specificity of autoantibodies in autoimmune thrombocytopenia
26. Regulation of immune responses by TGF-β
27. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry
28. Chronic idiopathic thrombocytopenic purpura
29. Antigen-driven bystander suppression after oral administration of antigen
30. T-cell abnormalities in patients with idiopathic thrombocytopenic purpura: The presence of OKT4+8+ cells
31. Increased circulating Ia-positive T cells in patients with idiopathic thrombocytopenic purpura
32. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties
33. The expanding universe of T-cell subsets: Th1, Th2 and more
34. Differences in T cell subsets between men and women with idiopathic thrombocytopenic purpura
35. Significance of cytokines and CD68-positive microparticles in immune thrombocytopenic purpura
36. Treatment of uveitis by oral administration of retinal antigens: Results of a phase I/II randomized masked trial
37. A critical role for transforming growth factor-β but not interleukin 4 in the suppression of T helper type I-mediated colitis by CD45RB(low) CD+ T cells
38. Th1 and Th2 subsets in human diseases
39. An update on the human Th1 and Th2 cells
40. T lymphocyte subpopulations in idiopathic thrombocytopenic purpura (ITP)
41. Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia
42. Suppressed natural killer cell activity in patients with chronic autoimmune thrombocytopenic purpura
43. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: Relationship to platelet phenotype and platelet T-cell reactivity
44. Alterations in Tγ cells in patients with chronic idiopathic thrombocytopenic purpura
45. Effects of oral administration of collagen on rheumatoid arthritis
46. Elevated numbers of gamma-delta (γδ+) T lymphocytes in children with immune thrombocytopenic purpura
47. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases
48. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis
49. Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic ITP
50. Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura
51. Human macrophage colony-stimulating factor levels are elevated in pregnancy and in immune thrombocytopenia